Provisional drug overdose death counts for specific drugs

This data presents counts of provisional drug overdose deaths by selected drugs and U.S. Department of Health and Human Services (HHS) public health regions, based on provisional mortality data from the National Vital Statistics System. This data is limited to drug overdose deaths with an underlying cause of death assigned to International Statistical Classification of Diseases, 10th Revision (ICD-10) code numbers X40-X44 (unintentional), X60-X64 (suicide), X85 (homicide), or Y10-Y14 (undetermined intent). Specific drugs were identified using methods for searching literal text from death certificates.

The provisional data are based on a current flow of mortality data and include reported 12 month-ending provisional counts of drug overdose deaths by jurisdiction of occurrence and specified drug. Provisional drug overdose death counts presented on this page are for “12-month ending periods,” defined as the number of deaths occurring in the 12-month period ending in the month indicated. For example, the 12-month ending period in June 2022 would include deaths occurring from July 1, 2021, through June 30, 2022. Evaluation of trends over time should compare estimates from year to year (June 2021 and June 2022), rather than month to month, to avoid overlapping time periods. It is important to note that the data represent counts of deaths, and not mortality ratios or rates, which are the standard measure used to compare groups, and therefore should not be used to determine populations at disproportionate risk of drug overdose death.

本数据集展示了由选定药物引起的临时药物过量死亡人数，以及美国卫生与公众服务部（HHS）公共卫生区域的数据，基于国家生命统计系统提供的临时死亡率数据。该数据仅限于因死亡原因归因于国际疾病分类第十版（ICD-10）代码X40-X44（非故意）、X60-X64（自杀）、X85（他杀）或Y10-Y14（意图不明）的药物过量死亡。具体药物通过从死亡证明中搜索文字文本的方法进行识别。临时数据基于当前的死亡率数据流，包括按发生地和指定药物报告的12个月末临时药物过量死亡人数。本页上展示的临时药物过量死亡人数是指“12个月末期”，定义为在所指月份结束的12个月期间发生的死亡人数。例如，2022年6月的12个月末期包括从2021年7月1日至2022年6月30日发生的死亡。评估时间趋势时，应将年度估计值进行比较（例如，2021年6月和2022年6月），而不是按月比较，以避免时间重叠。值得注意的是，数据表示死亡人数，而非死亡率或比率，这是比较群体的标准度量，因此不应用于确定药物过量死亡风险不成比例的人群。